POSTER SESSION VI
Wednesday, March 5, 2008   —  1:00 PM - 4:00 PM
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
1 Quantification of Regulatory T-Cells in Sentinel Lymph Nodes of Breast Cancer Patients (145)
R Gupta, B Singh, L Chiriboga, S Demaria - NYU Medical Center, New York, NY 		Add
2 Performance of Intraoperative Axillary Sentinel Lymph Node Touch Prep Evaluation: Effect of Surgical Submission of "Suspicious" Sentinel Lymph Nodes (200)
J Meyer, H Mason, S Ganai, A Hornish, GM Crisi, RA Goulart - Baystate Medical Center/Tufts University School of Medicine, Springfield, MA 		Add
3 Isolated Tumor Cells on Sentinel Lymph Node Biopsy: Our Experience over a Decade (113)
F Darvishian, A Guth, S Dhage, B Singh, D Roses, D Axelrod, C Mercado, J Cangiarella - New York University Medical Center, New York, NY 		Add
4 Significance of Sentinel Lymph Node Positivity in Patients with a Core Biopsy Diagnosis of DCIS (154)
J Han, KH Molberg, VR Sarode - UT Southwestern Medical Center, Dallas, TX 		Add
5 False Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions (218)
Y Peng, R Ashfaq, G Ewing, AM Leitch, KH Molberg - UT Southwestern Medical Center, Dallas, TX 		Add
6 Standardizing Breast Sentinel Lymph Node Processing: The Role of a Real Time Reverse Transcriptase - Polymerase Chain Reaction Assay (246)
LJ Tafe, MC Schwab, JA Lefferts, WA Wells, GJ Tsongalis - Dartmouth Medical School, DHMC, Lebanon, NH 		Add
7 Is Measurement of Ki-67 in Axillary Lymph Node Metastasis of Breast Cancer Useful? (188)
X Liu, BF Kimler, M Davis, F Fan, P Thomas, O Tawfik - University of Kansas Medical Center, Kansas City, KS 		Add
8 Can Axillary Dissection Be Avoided in Patients with Sentinel Node Micrometastasis? The Role of Pathologic Assessment of Breast Tumors in Predicting Non-Sentinel Node Metastasis (146)
R Gupta, J Cangiarella, B Singh, A Guth, D Axelrod, D Roses, F Darvishian - NYU Medical Center, New York, NY 		Add
9 Histopathological Characteristics of Primary Tumor in Breast Cancer Patients with Isolated Tumor Cells in Sentinel Nodes (135)
R Ghai, M Hulvat, K Yao, S Sarkar, C Schermer, C Ersahin, PB Rajan - Loyola University Medical Center, Maywood 		Add
10 Histologic Predictors of False Negative Sentinel Lymph Nodes Following Preoperative Chemotherapy (240)
AN Shaye, J Shen, GV Babiera, MI Ross, F Meric-Bernstam, BW Feig, HM Kuerer, A Francis, FC Ames, KK Hunt, MZ Gilcrease - The University of Texas MD Anderson Cancer Center, Houston, TX 		Add
11 Evaluation of the Anterior Margins in Skin-Sparing Mastectomies for Breast Carcinoma: Pathologic Findings and Their Clinical Implications (171)
BW Joos, B Kruse, S Sahoo - University of Louisville, Louisville, KY 		Add
12 Failure of Intraoperative Margin Assessment in Breast Conserving Therapy of Invasive Breast Carcinoma Seems To Be Influenced by Associated DCIS (183)
SF Lax, K Prein, U Bargfrieder, R Hammer, P Steindorfer - General Hospital Graz West, Graz, Austria 		Add
13 What Is the Value of a Third Re-Excision in Breast Conserving Therapy? (179)
M Kuhn, N Wang, J Wasman, FW Abdul-Karim - University Hospitals Case Medical Center, Cleveland, OH 		Add
14 Impact of Additional Margins on Breast Conserving Surgery in Patients with Ductal Carcinoma In Situ (265)
YH Wen, DF Roses, DM Axelrod, AA Guth, RL Shapiro, R Berman, B Singh - New York University, New York, NY 		Add
15 Reduction Mammoplasty Specimens for Macromastia from Women 40 Years and Older Should Undergo More Thorough Histological Evaluation Than Younger Women. A Prospective Study (74)
AB Ambaye, A Goodwin, SE MacLennan, T Suppan, S Naud, DL Weaver - UVM, Burlington, VT 		Add
16 Novel Approaches to Breast Tissue Banking: The Duke Breast SPORE Experience (164)
CB Hutchinson, RC Dash, RC Bentley, JA Olson, J Geradts - Duke University Medical Center, Durham, NC 		Add
17 The Expression of Cytokeratin 5/6 in Invasive Lobular Carcinoma of the Breast: Evidence of a "Basal-Like" Subset (125)
O Fadare, D Hileeto - Wilford Hall Medical Center, Lackland AFB, TX; McMaster University, Hamilton, ON, Canada 		Add
18 Secretory Breast Carcinoma: A Low Grade Basal-Like Carcinoma Associated with Translocation (182)
M Lae, P Freneaux, MJ Birolini, A Coulomb, B Sigal Zafrani, X Sastre, A Vincent Salomon - Institut Curie, Paris, France 		Add
19 Mammary Paget's Disease Is Strongly Associated with PR Negative, HER2 Positive, and High-Grade Non-Basal Subtypes Ductal Carcinoma of the Breast (184)
T Lester, J Wang, P Bourne, H Bu, B Wei, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC; Huaxi Hospital of Sichuan University, Chengdu, Sichuan, China 		Add
20 Breast Carcinoma with Luminal Phenotype: Prognostic Significance of Pathological and Immunohistochemical Findings (77)
FI Aranda, G Peiró, M Planelles, M Niveiro, J Seguí, C Alenda, E Adrover Hospital General Univers., Alicante, Spain 		Add
21 EGFR as a Prognostic Marker in Women with Hormone Receptor and HER2/neu Negative Breast Cancers (192)
J Lu, LR Ylagan, MA Watson, K Trinkaus, TP Fleming, RL Aft - Washington Universtiy School of Medicine, St. Louis, MO 		Add
22 Expression of the Rho GTPase Cdc42 in Triple-Negative Breast Cancers, Including Metaplastic Carcinomas (234)
CL Schiller, WR Wiseman, EL Wiley, MZ Gilcrease, LK Diaz - Northwestern University and University of Illinois, Chicago, IL; UT MD Anderson Cancer Center, Houston, TX; Abbott Northwestern Hospital Virginia Piper Cancer Institute, Minneapolis, MN 		Add
23 CK5 Is More Sensitive Than CK5/6 in Identifying "Basal-Like" Carcinoma of the Breast (92)
R Bhargava, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA 		Add
24 A Comparative Histopathological and Clinical Study of "Triple-Negative" Invasive Mammary Carcinomas in African American and Caucasian Women (153)
S Hamidpour, BF Kimler, M Davis, S Hull, F Fan, QJ Khan, P Thomas, O Tawfik - Kansas University Medical Center, Kansas, KS 		Add
25 A Q-RT PCR Profile for the Cytological Diagnosis of Early Breast Lesions (254)
P Vielh, V Suciu, V Scott, P Dessen, I Laurent, F Andre, M Saghatchian, V Lazar, R Lidereau, S Michiels, S Delaloge - Institut Gustave Roussy, Villejuif, France; CRH, St. Cloud, France 		Add
26 Expression of EGFR, IL-1, Amphiregulin, and NFkB in Triple Negative Breast Cancer, and Their Correlation with Histologic Findings (253)
H Vakil, B Sharaf Aldeen, A Safadi, H Nassar - Wayne State University, Detroit, MI 		Add
27 Incidence of Medullary Carcinoma vs Other Histologic Types in Triple Negative and HER2+ Breast Carcinoma (205)
LA Niemeier, Z Zhang, O Alassi, O Ormsby, A Stark, D Schultz, U Raju - Henry Ford Hospital, Detroit, MI 		Add
28 Basal-Like Invasive Breast Carcinoma: How Specific Are Immunohistochemical Markers? (85)
GS Baird, LC Goldstein, AM Gown, TS Barry - PhenoPath Laboratories, Seattle, WA 		Add
29 RNA Binding Protein IMP3 Is a Novel Biomarker for Basal-Like Invasive Mammary Carcinoma and Is Associated with a More Aggressive Phenotype (263)
O Walter, M Prasad, C Hsieh, K Rock, A Khan - UMASS Medical School, Worcester, MA 		Add
30 Prognostic Significance of Basal and Luminal Markers in Triple-Negative Breast Cancer (79)
YK Bae, JM Kim, SH Kang, SJ Lee, E Gabrielson - Yeungnam University College of Medicine, Daegu, Korea; Johns Hopkins School of Medicine, Baltimore, MD 		Add